98%
921
2 minutes
20
Xylanase, a key enzyme in the saccharification of lignocellulosic biomass (LCB) for bioethanol production, often faces limitations due to its limited reusability and poor stability. For this purpose, β-1,4-xylanase gene (Clocl_0045) of 1239 bp from Clostridium clariflavum (also known as Acetivibrio clariflavus) was cloned and expressed into expression system i.e., E.coli BL21. A rational approach was developed to covalently immobilize cloned xylanase on iron oxide (FeO) magnetic nanoparticles (MNPs) coated with silica (SiO), enhancing stability, reusability, and recovery from the reaction system. Multiple alignment analysis and structural modeling studies revealed that recombinant xylanase contained a conserved GH (glycosyl hydrolase) domain. The enzyme's catalytic site included Glu-166 and Glu-271 residues for substrate binding. The successful immobilization of nano-coupled xylanase was analyzed using Fourier-transform infrared spectroscopy (FTIR) to observe changes in the shift, from CO to CN. Additionally, crystalline nature of iron oxide nanoparticles was confirmed by X-ray diffraction (XRD) analysis. The results indicated that the the immobilized xylanase exhibited activity of 6.45 ± 0.21 U/mL,metal ion stability with calcium ions, thermal stability at 90 °C after 4 h with residual activity of 38.5 % and pH stability with residual activity of 93.7 % at pH 7.0. Furthermore, the immobilized enzyme demonstrated enhanced residual activity in the reusability assay for upto 15 cycles on xylan (substrate) and 5 cycles on pretreated sugarcane bagasse. Saccharification time for pretreated biomasses was found to be 72 h. In conclusion, all these findings highlight the effectiveness and competitiveness of the immobilized xylanase with high reusability and stability for better industrial implementation.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.ijbiomac.2025.142169 | DOI Listing |
J Agric Food Chem
September 2025
The State Key Laboratory of Food Science and Resources, Jiangnan University, 1800 Lihu Road, Wuxi 214122, China.
This study develops a multienzyme coimmobilization strategy on NTA-functionalized ZIF-8-coated magnetic nanoparticles (NZMNPs) for efficient d-allulose synthesis. Under optimized immobilization conditions (enzyme-to-carrier ratio: 1:50 w/w, 30 min immobilization), the system achieved an immobilization efficiency of 93.7% along with 107.
View Article and Find Full Text PDFEnviron Sci Technol
September 2025
Nanjing Institute of Geography and Limnology, Chinese Academy of Sciences, Nanjing 210094, China.
Tracing footprint and risk of microplastics and microfibers is crucial to managing plastic and fiber waste. We identified microfibers from microplastics, quantitatively apportioned the sources of microplastics and microplastics in 102 lakes across China by field work, and developed a novel index (IMRI) to assess the risk based on human footprint and the abundance, size, shape, color, and residual monomers and chemical additives. The abundance in the sediments of these lakes ranged from 0.
View Article and Find Full Text PDFMol Ther Methods Clin Dev
June 2025
Eisai Co., Ltd., Tsukuba Research Laboratories, 5-1-3, Tokodai, Tsukuba, Ibaraki 300-2635, Japan.
Liver-humanized chimeric mice (PXB-mice) are widely utilized for predicting human pharmacokinetics (PK) and as human disease models. However, residual metabolic activity of mouse hepatocytes in chimeric mice can interfere with accurate human PK estimation. Lipid nanoparticle (LNP)-formulated small interfering RNA (siRNA) treatment makes it possible to eliminate the shortcomings of chimeras and create new models.
View Article and Find Full Text PDFBiomed Rep
November 2025
Department of Pediatric Neurology, King Fahad Specialist Hospital, Dammam 31444, Saudi Arabia.
Intraoperative electrocorticography (ECoG) represents a crucial tool for improving seizure outcomes during epilepsy surgeries by assisting in localization of the epileptogenic zones. There is a shortage of information in the literature regarding single-center experiences and long-term outcomes after ECoG-guided surgeries. Data are particularly scarce from the Eastern Mediterranean Region.
View Article and Find Full Text PDFJTO Clin Res Rep
October 2025
Clinical Research Center (CRC), Medical Pathology Center (MPC), Cancer Early Detection and Treatment Center (CEDTC), and Translational Medicine Research Center (TMRC), Chongqing University Three Gorges Hospital, Wanzhou District, Chongqing, People's Republic of China.
NUT carcinoma is a rare and highly aggressive malignancy characterized by rapid progression, resistance to conventional therapies, and an extremely poor prognosis. This report presents a 36-year-old patient with stage IIIB primary pulmonary NUT carcinoma who achieved remarkable clinical outcomes with NHWD-870 monotherapy, a novel BET inhibitor. After just 1 month of treatment, imaging revealed a partial response, and a complete response was achieved within 5 months.
View Article and Find Full Text PDF